Telaprevir for HIV/Hepatitis C Virus-Coinfected Patients Failing Treatment With Pegylated Interferon/Ribavirin (ANRS HC26 TelapreVIH): An Open-Label, Single-Arm, Phase 2 Trial

✍ Scribed by Cotte, L.; Braun, J.; Lascoux-Combe, C.; Vincent, C.; Valantin, M.-A.; Sogni, P.; Lacombe, K.; Neau, D.; Aumaitre, H.; Batisse, D.; de Truchis, P.; Gervais, A.; Michelet, C.; Morlat, P.; Vittecoq, D.; Rosa, I.; Bertucci, I.; Chevaliez, S.; Aboulker, J.-P.; Molina, J.-M.; Aumaitre, H.; Batisse, D.; Bernard, L.; Cheret, A.; Cotte, L.; de Truchis, P.; Dellamonica, P.; Dominguez, S.; Gervais, A.; Girard, P.-M.; Lucht, F.; Metivier, S.; Michelet, C.; Molina, J.-M.; Morlat, P.; Neau, D.; Pageaux, G. P.; Pol, S.; Rosa, I.; Rosenthal, E.; Vittecoq, D.; Valantin, M.-A.; Zucman, D.

• Book ID: 127230882
• Publisher: University of Chicago Press
• Year: 2014
• Tongue: English
• Weight: 525 KB
• Volume: 59
• Category: Article
• ISSN: 1058-4838
• DOI: 10.1093/cid/ciu659